Literature DB >> 8651243

Pattern of glomerular disease in Saudi Arabia.

A H Mitwalli1, J S Al Wakeel, S S Al Mohaya, H G Malik, H Abu-Aisha, O S Hassan, M Akhtar.   

Abstract

Clinical data and renal biopsy study of 186 adult patients found to have nephropathy and seen at the Security Forces Hospital, Riyadh, over a 5-year period (1989 to 1994) were reviewed. Primary glomerular disease accounted for more than three fourths of all patients (79%), and the most common histological lesion was focal segmental glomerulosclerosis (40.8%) associated with a high incidence of hypertension (86.7%), nephrotic syndrome (61.7%), hematuria (48.8%), and renal impairment (33.3%). Mesangioproliferative glomerulonephritis was the second most common lesion (21.1%), followed by membreous glomerulonephritis (13.6%), immunoglobulin A nephropathy (IgAN) (13.6%), membranoproliferative glomerulonephritis (9.5%), and minimal change disease (1.4%). Although not as common as in most other developed countries, IgAN is being increasingly recognized in Saudis. Lupus nephritis remained the commonest cause of secondary glomerulonephritis (48.5%), whereas amyloidosis was conspicuously absent. There is no evidence, at least in this series, that chronic infection such as hepatitis B virus infection has a major role in the development of glomerulonephritis.

Entities:  

Mesh:

Year:  1996        PMID: 8651243     DOI: 10.1016/s0272-6386(96)90516-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  14 in total

1.  A 5-year survey of biopsy proven kidney diseases in Lebanon: significant variation in prevalence of primary glomerular diseases by age, population structure and consanguinity.

Authors:  Hussein H Karnib; Ali G Gharavi; Georges Aftimos; Ziyad Mahfoud; Reem Saad; Elias Gemayel; Badiaa Masri; Shafika Assaad; Kamal F Badr; Fuad N Ziyadeh
Journal:  Nephrol Dial Transplant       Date:  2010-06-04       Impact factor: 5.992

2.  Varied Presentations of Acute Glomerulonephritis in Children: Single centre experience from a developing country.

Authors:  Kalpana Malla; Moinak S Sarma; Tejesh Malla; Anna Thaplial
Journal:  Sultan Qaboos Univ Med J       Date:  2008-07

3.  Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics.

Authors:  T M El Mansoury; B P C Hazenberg; S A El Badawy; A H Ahmed; J Bijzet; P C Limburg; M H van Rijswijk
Journal:  Ann Rheum Dis       Date:  2002-01       Impact factor: 19.103

4.  Kidney biopsy in west of Iran: Complications and histopathological findings.

Authors:  M Rahbar
Journal:  Indian J Nephrol       Date:  2009-04

5.  Etiological profile of nephrotic syndrome in Kashmir.

Authors:  A R Reshi; M A Bhat; M S Najar; K A Banday; M A Naik; D P Singh; F Wani
Journal:  Indian J Nephrol       Date:  2008-01

6.  Renal biopsy findings in acute renal failure in the cohort of patients in the Spanish Registry of Glomerulonephritis.

Authors:  Juan M López-Gómez; Francisco Rivera
Journal:  Clin J Am Soc Nephrol       Date:  2008-03-19       Impact factor: 8.237

7.  Lupus nephritis among 624 cases of systemic lupus erythematosus in Riyadh, Saudi Arabia.

Authors:  Abdurahman Saud Al Arfaj; Najma Khalil; Salman Al Saleh
Journal:  Rheumatol Int       Date:  2009-04-21       Impact factor: 2.631

8.  The spectrum of glomerular diseases on renal biopsy: data from a single tertiary center in oman.

Authors:  Dawood Al Riyami
Journal:  Oman Med J       Date:  2013-05

9.  Spectrum of glomerulonephritides in adults with nephrotic syndrome in Pakistan.

Authors:  Javed Iqbal Kazi; Muhammed Mubarak; Ejaz Ahmed; Fazal Akhter; Syed Ali Anwer Naqvi; Syed Adeebul Hassan Rizvi
Journal:  Clin Exp Nephrol       Date:  2008-08-07       Impact factor: 2.801

10.  Glomerular diseases in the Military Hospital of Morocco: Review of a single centre renal biopsy database on adults.

Authors:  T Aatif; O Maoujoud; D I Montasser; M Benyahia; Z Oualim
Journal:  Indian J Nephrol       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.